News

CureMatch Selected by San Diego Venture Group as a “2017 Cool Company”

SAN DIEGO, CA – May 20, 2017 –CureMatch™ today was selected by the San Diego Venture Group as one of its 2017 Cool Companies. SDVG’s list of Cool Companies are those determined to be “venture-ready” and among the “fastest-growing, most exciting startups in Southern California.” The Fastest-Growing, Most Exciting Startups in San Diego A total of 37 […]

CureMatch Announces Pricing for its Cutting-Edge Combination Therapy Report for Cancer Treatment

Cancer Combination Therapy Personalized Medicine

CureMatch makes it affordable for all to get personalized cancer treatment, and offers the decision support system service for free for children with cancer SAN DIEGO, CA – May 25, 2017 –CureMatch™ today announced the pricing for its Personalized Combination Therapy™ report. The report guides oncologists in the selection of cancer treatment options that are […]

CureMatch Case Study Featured in Hatch Magazine

Combination Therapy Genomic Sequencing Melanoma

A recent CureMatch case study was described in Hatch magazines “Startup Buzz” feature. Click here to read more.

CureMatch Correctly Ranks Successful Therapy in Metastatic Melanoma Case

BRAF Cancer Combination Therapy Melanoma

In this case study, a patient with metastatic melanoma was given multiple lines of chemotherapy that were ineffective. The patient’s oncologist subsequently selected a combination of two targeted drugs that led to a remarkable response. This was done “blindly”, i.e., without any genomic sequencing data from the tumor, based on the experience of the oncologist. This […]

CureMatch Explainer Video: Explore the Landscape of Cancer Treatment…from a Boat

Cancer Cancer Mutations Cancer Treatment

Cancer mutations are like holes in a sinking boat. Watch this short cartoon to learn about cancer treatment and how personalized combination therapy can be used treat cancer.

Interview with Dr. Razelle Kurzrock of CureMatch: Why Patients Need Precision Cancer Medicine
In this dynamic interview, Chief Medical Advisor, Dr. Kurzrock, sits down with Michelle Morand, Co-Founder...
New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs
The Research Consortium announced the release of a new study today that challenges common misconceptions...
CureMatch Names Life Sciences Executive David Szekeres as Board Director
CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine...
CureMatch Appoints Healthcare Executive Dale Brown as Board Director
CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine...
CureMatch and CureMetrix Align to Support President Biden’s Relaunch of Cancer Moonshot
In response to President Biden’s relaunch of Cancer Moonshot and his White House commitment to...
CureMatch CEO – 15 top leaders propelling the technology industry forward
Innovation in these companies varies from better user experiences to democratizing access. From health care...
Dr Razelle Kurzrock Of CureMatch On The 5 Things Everyone Needs To Know About Cancer
In this interview series called, “5 Things Everyone Needs To Know About Cancer” we are...

CureMatch Selected by San Diego Venture Group as a “2017 Cool Company”

CureMatch Announces Pricing for its Cutting-Edge Combination Therapy Report for Cancer Treatment

CureMatch Case Study Featured in Hatch Magazine

CureMatch Correctly Ranks Successful Therapy in Metastatic Melanoma Case

CureMatch Explainer Video: Explore the Landscape of Cancer Treatment…from a Boat

We’d like to send you a CureMatch Sample Analysis

Sample Analysis Download Form

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data